Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1177/1591019920954603 http://scihub22266oqcxt.onion/10.1177/1591019920954603 32862753!7586005!32862753     free     free     free       Interv+Neuroradiol 2020 ; 26 (5): 623-628 Nephropedia Template TP {{tp|p=32862753|t=2020. Predictors of mortality for patients with COVID-19 and large vessel occlusion |pdf=|usr=}}{{32862753}} gab.com Text Predictors of mortality for patients with COVID-19 and large vessel occlusion JO: Interv Neuroradiol http://www.kidney.de/pget.php?&tw=1&pmid=32862753 #FOAvip BACKGROUND: This study evaluates the mortality risk of patients with emergent large vessel occlusion (ELVO) and COVID-19 during the pandemic. METHODS: We performed a retrospective cohort study of two cohorts of consecutive patients with ELVO admitted to a quaternary hospital from March 1 to April 17, 2020. We abstracted data from electronic health records on baseline, biomarker profiles, key time points, quality measures and radiographic data. RESULTS: Of 179 patients admitted with ischemic stroke, 36 had ELVO. Patients with COVID-19 and ELVO had a higher risk of mortality during the pandemic versus patients without COVID-19 (OR 16.63, p = 0.004). An age-based sub-analysis showed in-hospital mortality in 60% of COVID-19 positive patients between 61-70 years-old, 66.7% in between 51-60 years-old, 50% in between 41-50 years-old and 33.3% in between 31-40 years old. Patients that presented with pulmonary symptoms at time of stroke presentation had 71.4% mortality rate. 27.3% of COVID-19 patients presenting with ELVO had a good outcome at discharge (mRS 0-2). Patients with a history of cigarette smoking (p = 0.003), elevated d-dimer (p = 0.007), failure to recanalize (p = 0.007), and elevated ferritin levels (p = 0.006) had an increased risk of mortality. CONCLUSION: Patients with COVID-19 and ELVO had a significantly higher risk for mortality compared to COVID-19 negative patients with ELVO. A small percentage of COVID-19 ELVO patients had good outcomes. Age greater than 60 and pulmonary symptoms at presentation have higher risk for mortality. Other risk factors for mortality were a history of cigarette smoking, elevated, failure to recanalize, elevated d-dimer and ferritin levels. Twit Text FOAVip Predictors of mortality for patients with COVID-19 and large vessel occlusion ????Interv Neuroradiol http://www.kidney.de/pget.php?&tw=1&pmid=32862753 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32862753 #FOAvip English Wikipedia <ref>{{Cite pmid|32862753}}</ref> Predictors of mortality for patients with COVID-19 and large vessel occlusion #MMPMID32862753 Altschul DJ; Esenwa C; Haranhalli N; Unda SR; de La Garza Ramos R; Dardick J; Fernandez-Torres J; Toma A; Labovitz D; Cheng N; Lee SK; Brook A; Zampolin R Interv Neuroradiol 2020[Oct]; 26 (5): 623-628 PMID32862753show ga BACKGROUND: This study evaluates the mortality risk of patients with emergent large vessel occlusion (ELVO) and COVID-19 during the pandemic. METHODS: We performed a retrospective cohort study of two cohorts of consecutive patients with ELVO admitted to a quaternary hospital from March 1 to April 17, 2020. We abstracted data from electronic health records on baseline, biomarker profiles, key time points, quality measures and radiographic data. RESULTS: Of 179 patients admitted with ischemic stroke, 36 had ELVO. Patients with COVID-19 and ELVO had a higher risk of mortality during the pandemic versus patients without COVID-19 (OR 16.63, p = 0.004). An age-based sub-analysis showed in-hospital mortality in 60% of COVID-19 positive patients between 61-70 years-old, 66.7% in between 51-60 years-old, 50% in between 41-50 years-old and 33.3% in between 31-40 years old. Patients that presented with pulmonary symptoms at time of stroke presentation had 71.4% mortality rate. 27.3% of COVID-19 patients presenting with ELVO had a good outcome at discharge (mRS 0-2). Patients with a history of cigarette smoking (p = 0.003), elevated d-dimer (p = 0.007), failure to recanalize (p = 0.007), and elevated ferritin levels (p = 0.006) had an increased risk of mortality. CONCLUSION: Patients with COVID-19 and ELVO had a significantly higher risk for mortality compared to COVID-19 negative patients with ELVO. A small percentage of COVID-19 ELVO patients had good outcomes. Age greater than 60 and pulmonary symptoms at presentation have higher risk for mortality. Other risk factors for mortality were a history of cigarette smoking, elevated, failure to recanalize, elevated d-dimer and ferritin levels. |Adult[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |Arterial Occlusive Diseases/*mortality[MESH] |COVID-19[MESH] |Cohort Studies[MESH] |Coronavirus Infections/*complications/*mortality[MESH] |Female[MESH] |Ferritins/blood[MESH] |Fibrin Fibrinogen Degradation Products/analysis[MESH] |Hospital Mortality[MESH] |Humans[MESH] |Lung Diseases/etiology/mortality[MESH] |Male[MESH] |Middle Aged[MESH] |Pandemics[MESH] |Pneumonia, Viral/*complications/*mortality[MESH] |Predictive Value of Tests[MESH] |Retrospective Studies[MESH] |Risk Assessment[MESH] |Risk Factors[MESH] |Smoking/mortality[MESH] |Stroke/etiology/mortality[MESH]Predictors of mortality for patients with COVID-19 and large vessel oc(epmc).pdf DeepDyve Pubget Overpricing